Thursday, the FDA rejected Eli Lilly’s Alzheimer’s disease candidate, donanemab, an investigational antibody to ameliorate the symptoms of Alzheimer’s disease (AD). While the news may have disappointed the company, some AD experts asserted the FDA’s actions were appropriate. What’s more, Lilly’s approach with donanemab is misdirected, critics suggested. Because donanemab works chiefly to remove plaques in the brain, without […]

Drug overdoses accounted for more than 109,000 deaths in 2021 in the United States , an astounding 43% surge from 76,000 deaths just the year before. A recent study  predicted another 1.2 million opioid overdose deaths by the end of this decade. And absent from these numbers is the toll on the hundreds of thousands of people who suffer […]

The medtech industry is evolving more quickly than ever, spurred along by lessons learned from the COVID-19 pandemic, an increasingly digital-friendly patient population and tech developments that are bringing artificial intelligence, augmented and virtual reality and other once-futuristic concepts firmly into the present. That rapidly shifting landscape has created an especially Darwinian environment, one in which […]